Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT02294487
Official study title

Study of the Immune Response After Vaccination in Multiple Myeloma Patients

Study summary

This study will collect blood samples from healthy volunteers and volunteers with multiple myeloma who are going to get the seasonal flu, pneumonia, haemophilus influenzae B (HIB), and/or meningococcus vaccines. The main goal of the study is to start to identify differences in the immune response between multiple myeloma patients and people who don't have multiple myeloma. We hope this will provide important information about the best way and time to vaccinate multiple myeloma patients to flu, pneumonia, haemophilus influenzae B (HIB), and/or meningococcus .

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedNot specified

The study team can explain what participation involves.

Who it may be forMultiple Myeloma · Myeloma, Multiple

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Oct 3, 2024 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Wake Forest University Health Sciences

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Wake Forest University Health Sciences
Interventions being studied
Not specified
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • 50 years old or over
  • planning on getting the seasonal flu and/or pneumonia vaccine as part of normal care
  • have multiple myeloma, or don't have multiple myeloma and want to serve as a health control
Reasons someone may not be able to joinExclusion criteria

\- do not meet inclusion criteria

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Aurora Health CareMilwaukee, Wisconsin

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 3, 2024. Always confirm current availability with the study team.

View original record ↗